To change the world for people with serious cardiovascular diseases through bold and innovative science, we’re pioneering a precision medicine approach to treating cardiomyopathies and other forms of heart failure that results from biomechanical defects in cardiac muscle contraction.
Phase 3
Phase 2
Phase 2
Phase 1
Preclinical
Preclinical
Research
Clinical Development
Medical Affairs
Sep 15, 2019
Sep 12, 2019
Sep 08, 2019
Life at MyoKardia